November 7, 2024

What’s next for reproductive rights in the US

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. Earlier this week, Americans cast their votes in a seminal presidential election. But it wasn’t just the future president of the US that was on the ballot. Ten…

Cultivating the next generation of AI innovators in a global tech hub

October 29, 2024
A few years ago, I had to make one of the biggest decisions of my life: continue as a professor at the University of Melbourne or move to another part of the world to help build a brand new university focused entirely on artificial intelligence. With the rapid development we have seen in AI over…

The Download: mysterious exosomes, and AI’s e-waste issue

October 29, 2024
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Exosomes are touted as a trendy cure-all. We don’t know if they work. There’s a trendy new cure-all in town—you might have seen ads pop up on social media or read rave reviews…

Palmer Luckey’s vision for the future of mixed reality

October 29, 2024
This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. War is a catalyst for change, an expert in AI and warfare told me in 2022. At the time, the war in Ukraine had just started, and the military AI business was…

Exosomes are touted as a trendy cure-all. We don’t know if they work.

October 29, 2024
There’s a trendy new cure-all in town—you might have seen ads pop up on social media or read rave reviews in beauty magazines. Exosomes are being touted as a miraculous treatment for hair loss, aging skin, acne, eczema, pain conditions, long covid, and even neurological diseases like Parkinson’s and Alzheimer’s. That’s, of course, if you…